Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations

BACKGROUND: Syndecan-1 (sCD138) has recently been suggested to predict the clinical course of early-stage chronic lymphocytic leukemia (CLL), but few studies have been reported. This study assessed the role of syndecan-1 in the prognosis of patients with CLL and its correlation with other prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Monica, Tyagi, Seema, Tripathi, Preeti, Seth, Tulika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170314/
https://www.ncbi.nlm.nih.gov/pubmed/30310786
http://dx.doi.org/10.5045/br.2018.53.3.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170314/
https://www.ncbi.nlm.nih.gov/pubmed/30310786
http://dx.doi.org/10.5045/br.2018.53.3.205

Ejemplares similares